Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

IG Compliance Guide Will Change PBM Rebate Policies, AdvancePCS Says

Executive Summary

The HHS Inspector General's compliance guide for pharmaceutical manufacturers will "push" pharmacy benefit management companies to reform their drug rebate policies, AdvancePCS CEO David Halbert suggested at the SG Cowen health care conference in Boston March 19
Advertisement

Related Content

Medco Injunction Means Switches Have “Consequences,” Prosecutor Says
PBM Contracts Should Focus On Net Cost, Not Rebates, Express Scripts Says
PBM Safe Harbor Compliance May Cause “Difficulty” With Manufacturers
PBM Accounting: Express Scripts Says Retail Rx Copays Are Not Revenue
Medco Lets Snow Reign: CEO David Snow Joins PBM From WellChoice
PBM Association Picks PhRMA’s Merritt To Lead Image Renewal Effort
IG Rx Compliance Guide Sets PhRMA Marketing Code As Minimum Threshold
IG Rx Compliance Guide Sets PhRMA Marketing Code As Minimum Threshold
Express Scripts Sees No Commercial Risk From Lupron Subpoena
AdvancePCS Tapping Into Rx Marketing Budgets For Revenues
Advertisement
UsernamePublicRestriction

Register

PS041484

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel